Population pharmacokinetics and limited sampling strategies of polymyxin B in critically ill patients
Journal of Antimicrobial Chemotherapy · 02.03.2023 · 78 (3) · 792-801
DOI: 10.1093/jac/dkad012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 26.01.2023. Verfasst von Meng-Ying Pi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital, Sun Yat-Sen University, No. 58, Zhongshan 2nd Road, 510080, Guangzhou, China. Hauptthemen laut MEDLINE: Polymyxin B, Critical Illness. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Objectives
To characterize the pharmacokinetics (PK) of polymyxin B in Chinese critically ill patients. The factors significantly affecting PK parameters are identified, and a limited sampling strategy for therapeutic drug monitoring of polymyxin B is explored.
Methods
Thirty patients (212 samples) were included in a population PK analysis. A limited sampling strategy was developed using Bayesian estimation, multiple linear regression and modified integral equations. Non-linear mixed-effects models were developed using Phoenix NLME software.
Results
A two-compartment population PK model was used to describe polymyxin B PK. Population estimates of the volumes of central compartment distribution (V) and peripheral compartment distribution (V2), central compartment clearance (CL) and intercompartmental clearance (Q) were 7.857 L, 12.668 L, 1.672 L/h and 7.009 L/h. Continuous renal replacement therapy (CRRT) significantly affected CL, and body weight significantly affected CL and Q. The AUC0-12h of polymyxin B in patients with CRRT was significantly lower than in patients without CRRT. CL and Q increased with increasing body weight. A limited sampling strategy was suggested using a two-sample scheme with plasma at 0.5h and 8h after the end of infusion (C0.5 and C8) for therapeutic drug monitoring in the clinic.
Conclusions
A dosing regimen should be based on body weight and the application of CRRT. A two-sample strategy for therapeutic drug monitoring could facilitate individualized treatment with polymyxin B in critically ill patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The First Affiliated Hospital, Sun Yat-Sen University, No. 58, Zhongshan 2nd Road, 510080, Guangzhou, China.
- School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China.
- Department of Critical Care Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
- Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China.
ORCID-Profile: Xiao Chen, Guo-Ping Zhong, Yan-Zhe Xia
Zitieren
APA
Pi, M. Y., Cai, C. J., Zuo, L. Y., Zheng, J. T., Zhang, M. L., Lin, X. B., Chen, X., Zhong, G. P., & Xia, Y. Z. (2023). Population pharmacokinetics and limited sampling strategies of polymyxin B in critically ill patients. Journal of Antimicrobial Chemotherapy, 78(3), 792-801. https://doi.org/10.1093/jac/dkad012
Vancouver
Pi MY, Cai CJ, Zuo LY, Zheng JT, Zhang ML, Lin XB, et al. Population pharmacokinetics and limited sampling strategies of polymyxin B in critically ill patients. Journal of Antimicrobial Chemotherapy. 2023;78(3):792-801. doi:10.1093/jac/dkad012
BibTeX
@article{Pi2023,
author = {Pi, Meng-Ying and Cai, Chang-Jie and Zuo, Ling-Yun and Zheng, Jun-Tao and Zhang, Miao-Lun and Lin, Xiao-Bin and Chen, Xiao and Zhong, Guo-Ping and Xia, Yan-Zhe},
title = {Population pharmacokinetics and limited sampling strategies of polymyxin B in critically ill patients},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2023},
volume = {78},
number = {3},
pages = {792--801},
doi = {10.1093/jac/dkad012}
}
EUVIMED